Právní předpis byl sestaven k datu 02.07.2026.
Zobrazené znění právního předpisu je účinné od 22.02.2023.
Sdělení Ministerstva zdravotnictví o antigenním složení očkovacích látek pro pravidelná, zvláštní a mimořádná očkování pro rok 2023
41/2023 Sb.
41
SDĚLENÍ
Ministerstva xxxxxxxxxxxxx
xx xxx 10. xxxxx 2023
x xxxxxxxxxx složení očkovacích xxxxx xxx xxxxxxxxxx, xxxxxxxx x xxxxxxxxx xxxxxxxx xxx xxx 2023
&xxxx;
Xxxxxxxxxxxx xxxxxxxxxxxxx xxxxx §80 xxxx. 1 xxxx. x) xxxxxx x. 258/2000 Sb., x xxxxxxx xxxxxxxxx xxxxxx x o xxxxx xxxxxxxxx xxxxxxxxxxxxx xxxxxx, ve xxxxx xxxxxxxxxx předpisů, xxxxxxx xx xxxxxxx doporučení Xxxxxxx imunizační komise xxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx pro xxxxxxxxxx, xxxxxxxx x mimořádná xxxxxxxx pro rok 2023:
1. Antigenní xxxxxxx xxxxxxxxxx xxxxx xxx xxxxxxxxxx xxxxxxxx
1x) xxxxxxxxxxx xxxxxxxx xxxxx xxxxx xxxxxxx, dávivému xxxxx (xxxxxxxxxx xxxxx), tetanu, xxxxxx xxxxxxxx xxxxx (xxxxxxxxxxxx xxxxx), virové xxxxxxxxxx B, xxxxxxx xxxxxxxxx Haemophilus xxxxxxxxxx xxx x (XXxXXxxXXXXXX)
Xx xxxxxxxxxxxx 1 xxxxx (0,5 xx) obsahuje:
Diphtheriae xxxxxxxxxx1 xx xxxx xxx 30 xxxxxxxxxxxxx xxxxxxxx (XX)
Xxxxxx xxxxxxxxxx1 xx méně xxx 40 xxxxxxxxxxxxx jednotek (XX)
Xxxxxxxx Bordetelly xxxxxxxxx:
Xxxxxxxxx xxxxxxxxxx (XX)1 25 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxxxxxxxxx filamentosum (XXX)1 25 xxxxxxxxxx Xxxxxxxxxxx (PRN)1 8 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X (XXx)2,3 10 xxxxxxxxxx
Xxxxx xxxxxxxxxxxxxxx xxxxxxxxxxx (XXX)
xxxxx 1 (xxxx Xxxxxxx)4 40 D xxxxxxxx xxxxxxxx
xxxxx 2 (xxxx XXX-1)4 8 X jednotek xxxxxxxx
xxxxx 3 (xxxx Xxxxxxx)4 32 X xxxxxxxx xxxxxxxx
Xxxxxxxxxxx influenzae xxxxx x polysaccharidum
(Polyribosylribitoli phosphas) 10 xxxxxxxxxx
xxxx. xxx xxxxxx. xxxxxxxx xxxx xxxxx xxxxxxx přibližně 25 xxxxxxxxxx
1 adsorbováno xx xxxxxxxx xxxxxxx, xxxxxxxxxxx (Xx(XX)3) 0,5 xxxxxxxxx Xx3+
2 xxxxxxxx xxxxxxxxxxxxx XXX xxxxxxxxxxx xx xxxxxxx xxxxxxxxxxxx xxxxx Xxxxxxxxxxxxx xxxxxxxxxx)
3 xxxxxxxxxxx xx fosforečnan xxxxxxx (XxXX4) 0,32 xxxxxxxxx Al3+
4 pomnoženo xx VERO xxxxxxx
XXXX
1xx) xxxxxxxxxxx xxxxxxxx xxxxx xxxxx xxxxxxx, dávivému xxxxx (acelulární forma), xxxxxx, xxxxxx xxxxxxxx xxxxx (xxxxxxxxxxxx xxxxx), xxxxxx hepatitidě B, xxxxxxx xxxxxxxxx Xxxxxxxxxxx xxxxxxxxxx xxx x (XXxXXxxXXXXXX)
Xxxxx xxxxx1 (0,5 xx) obsahuje:
Diphtheriae anatoxinum xx xxxx než 20 xxxxxxxxxxxxx xxxxxxxx (XX)2
Xxxxxx xxxxxxxxxx ne xxxx xxx 40 xxxxxxxxxxxxx xxxxxxxx (XX)2
Xxxxxxxx Xxxxxxxxxx xxxxxxxxx
Xxxxxxxxx anatoxinum 25 xxxxxxxxxx
Xxxxxxxxxxxxxx xxxxxxxxxxxx 25 mikrogramů
Virus Xxxxxxxxxxxxxxx (xxxxxxxxxxxx)3
xxxxx 1 (Mahoney) 40 D xxxxxxxx xxxxxxxx4
xxxxx 2 (MEF-1) 8 D xxxxxxxx xxxxxxxx4
xxxxx 3 (Xxxxxxx) 32 X xxxxxxxx xxxxxxxx4
Xxxxxxxxx xxxxxxxxx hepatitidis X5 10 xxxxxxxxxx
Xxxxxxxxxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxxxx X 12 xxxxxxxxxx
(Xxxxxxxxxxxxxxxxxxx xxxxxxxx)
xxxxxxxxx xxx tetani xxxxxxxxxx 22-36 xxxxxxxxxx
1 xxxxxxxxxxx xx xxxxxxxxxxx xxxxxxxx xxxxxxx (0,6 xx Al3+)
2 xxxx xxxxxx xxx xxxxxxxxxxxxx (x = 0,95)
3 xxxxxxxxx xx XXXX xxxxxxx
4 xxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxx stanovené xxxxxxx imunochemickou xxxxxxx
5 xxxxxxxx xxxxxxxxxxxxx DNA xxxxxxxxxxx v xxxxxxxxxxxx xxxxxxx Xxxxxxxxx xxxxxxxxxx
XXXX
1xx) Xxxxxxx xxxxx xxxxxxx, xxxxxx, dávivému xxxxx (xxxxxxxxxx komponenta), hepatitidě X (xXXX), xxxxxx xxxxxxxx xxxxx (inaktivovaná) x xxxxxxxxxxx xxxxxxx xxxxx Haemophilus xxxx x (adsorbovaná)
Jedna xxxxx (0,5 ml) xxxxxxxx:
Xxxxxxxxxxx xxxxxxxxxx1 xx xxxx xxx 20 XX
Xxxxxx xxxxxxxxxx1 xx xxxx xxx 40 IU
Antigena Xxxxxxxxxxx xxxxxxxx1
Xxxxxxxxx xxxxxxxxxx (XX) 20 xxxxxxxxxx
Xxxxxxxxxxxxxxx xxxxxxxxxxxx (FHA) 20 xxxxxxxxxx
Xxxxxxxxxxx (XXX) 3 xxxxxxxxxx
Xxxxxxxx xxxx 2 xx 3 (XXX) 5 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X2,3 10 xxxxxxxxxx
Xxxxx xxxxxxxxxxxxxxx (xxxxxxxxxxx)4
Xxxxx 1 (Xxxxxxx) 40 X xxxxxxxx antigenu5
Typus 2 (MEF-1) 8 X xxxxxxxx xxxxxxxx5
Xxxxx 3 (Xxxxxxx) 32 X jednotek xxxxxxxx5
Xxxxxxxxxxxxxx Xxxxxxxxxx influenzae xxxxx x
(Xxxxxxxxxxxxxxxxxxx xxxxxxxx) 3 xxxxxxxxxx xxxxxxxxxx xxx xxxxxxxxx xxxxxxxxxxxx typus x2 50 mikrogramů
1 xxxxxxxxxxx xx xxxxxxxxxxx xxxxxxx (0,17 mg Xx3+)
2 xxxxxxxxxxx xx xxxxxxxxxxx xxxxxxxx xxxxxxx xxxxxx (0,15 xx Xx3+)
3 vyrobeno rekombinantní XXX xxxxxxxxxxx x xxxxxxxxxxxx xxxxxxx Xxxxxxxxxxxxx xxxxxxxxxx
4 pomnoženo xx Xxxx buňkách
5 nebo xxxxxxxxxxxx xxxxxxxx xxxxxxxx xxxxxxxxx xxxxxxx imunochemickou xxxxxxx.
1x) xxxxxxxx xxxxx xxxxx xxxxxxx, dávivému xxxxx (xxxxxxxxxx xxxxx), xxxxxx (XXxX)
Xxxxx dávka (0,5 xx) xxxxxxxx xxxx xxxxxx xxxxx:
Xxxxxxxxxxx xxxxxxxxxx* ≥ 30 XX
Xxxxxx xxxxxxxxxx* ≥ 40 XX
Xxxxxxxxx anatoxinum* (XX) 25 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxxxxx* (FHA) 25 xxxxxxxxxx
Xxxxxxxxxxx* (69 xX) 8 xxxxxxxxxx
* xxxxxxxxxxx xx xxxxxxxx xxxxxxx xxxxxx: 0,5 xxxxxxxxx
XXXX
1xx) Xxxxxxxx látka xxxxx záškrtu, xxxxxx x xxxxxxxx xxxxx (xxxxxxxxxx) xx xxxxxxxx xxxxxxx xxxxxxxx (Xxxx)
Xxxxx xxxxx (0,5 xx) xxxxxxxx:
Xxxxxxxxxxx anatoxinum - Xxxxxxxxx 2 XX* (2 Xx)
Xxxxxx anatoxinum - Xxxxxxxxx 20 XX* (5 Lf)
Pertusové xxxxxxxx
Xxxxxxxxx anatoxinum - 2,5 xxxxxxxxxx
Xxxxxxxxxxxxxx xxxxxxxxxxxx - 5 xxxxxxxxxx
Xxxxxxxxxxx - 3 mikrogramy
Fimbriae, xxxx 2 xx 3 - 5 xxxxxxxxxx
Xxxxxxxxxxx na xxxxxxxxxxx xxxxxxx - 1,5 xx (0,33 xx xxxxxxx)
* Jako xxxxxx xxxxxxx intervalu xxxxxxxxxxxxx (x = 0,95) xxxxxxxx xxxxxx podle xxxxx popsaného x Xxxxxxxxx lékopisu.
NEBO
1bb) Očkovací xxxxx proti xxxxxxx, xxxxxx x dávivému xxxxx (xxxxxxxxxx xxxxxxxxxx) xx xxxxxxxx xxxxxxx xxxxxxxx (Xxxx)
Xxxxx xxxxx (0,5 ml) obsahuje:
Diphtheriae xxxxxxxxxx1 xx méně xxx 2 xxxxxxxxxxx xxxxxxxx (XX) (2,5 Xx)
Xxxxxx xxxxxxxxxx1 xx xxxx xxx 20 xxxxxxxxxxxxx xxxxxxxx (XX) (5 Xx)
Xxxxxxxxxxx xxxxxxxxx xxxxxxxx:
Xxxxxxxxx xxxxxxxxxx1 8 xxxxxxxxxx
Xxxxxxxxx haemagglutinum xxxxxxxxxxxx1 8 mikrogramů
Pertussis xxxxxxxxx xxxxxxxx xxxxxxxxx1 2,5 xxxxxxxxxx
1 xxxxxxxxxxx xx xxxxxxxxxxx xxxxxxxx hlinitý (Xx(XX)3) 0,3 xxxxxxxxx Xx3+ x fosforečnan xxxxxxx (AlPO4) 0,2 xxxxxxxxx Xx3+
1x) xxxxxxxx xxxxx xxxxx nákazám xxxxxxxxx Haemophilus xxxxxxxxxx xxx x:
Xxxxx xxxxx xxxxxxxxxxxxx xxxxxxx xxxxxxxx:
Xxxxxxxxxxxxxxx Xxx purificatum (10 xxxxxxxxxx) cum Xxxxxxxxx xxxxxxxx (xxxxxxxxx 25 xxxxxxxxxx).
1x) očkovací xxxxx xxxxx xxxxxx:
Xxxxx xxxxx xxxxxxxx:
Xxxxxx anatoxinum - xxx. 40 xxxxxxxxxxxxx xxxxxxxx
1x) xxxxxxxx xxxxx xxxxx xxxxxx hepatitidě X v xxxxxx xxxxxxx:
Xxxxx dávka xxxxxxxx:
Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx B - 10 xxxxxxxxxx
1x) xxxxxxxx látka xxxxx xxxxxx hepatitidě X x xxxxxxx xxxxxxx
Xxxxx xxxxx xxxxxxxx:
Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx B - 20 mikrogramů
1g) očkovací xxxxx xxxxx xxxxxxxxxx, xxxxxxxxxx x xxxxxxxxx:
Xxxxx xxxxx xxxxxxxx:
Xxxxxxxxxxx xxxxx xxxxxxxxxx1 (Xxxxxxx) xxx. 103,0 xxxxxxxx xxxxx xxx xxxxxxxx xxxxxxx503
Xxxxxxxxxxx xxxxx attenuatum1 (XXX 4385) xxx. 103,0 xxxxxxxx dávka xxx xxxxxxxx xxxxxxx503
Xxxxxxxx xxxxx xxxxxxxxxx2 (Xxxxxx XX 27/3) xxx. 103,0 xxxxxxxx dávka pro xxxxxxxx kulturu503
1 pomnoženo xx xxxxxxx xxxxxxxx xxxxxx
2 xxxxxxxxx na xxxxxxxx diploidních buňkách (XXX-5)
3 50% xxxxxxxx xxxxx xxxxxxx kultury
NEBO
1ga) xxxxxxxx látka xxxxx xxxxxxxxxx, xxxxxxxxxx a xxxxxxxxx
Xx rozpuštění obsahuje xxxxx xxxxx (0,5 xx):
Xxxxx xxxxxxxxxxx1 xxxxx xxxxxxxxxx (xxxx Xxxxxx’ Xxxxxxxxx) xx méně xxx 1x103 XXXX50*
Xxxxx xxxxxxxxxxx1 vivum xxxxxxxxxx (xxxx Xxxxx Xxxx™, xxxxxxx B) xx xxxx xxx 12,5x103 XXXX50*
Xxxxx rubeolae2 xxxxx xxxxxxxxxx (xxxx Wistar XX 27/3) xx xxxx xxx 1x103 XXXX50*
* 50 % xxxxxxxx xxxxx xxxxxxx xxxxxxx
1 vyrobeno xx xxxxxxx xxxxxxxx xxxxxx.
2 xxxxxxxx xx xxxxxxxx xxxxxxxxxxx xxxxxxxx WI-38 xxxxxxxxxxxxx.
1x) xxxxxxxx xxxxx xxxxx dětské xxxxxxxx xxxxx x xxxxxxxxxxxx xxxxx:
Xxxxx dávka xxxxxxxx:
Xxxxx xxxxxxxxxxxxx xxxxxxxxxxx xxxxx 1 (Xxxxxxx).....40 xxxxxxxxxxx X xxxxxxxx*
Xxxxx poliomyelitis xxxxxxxxxxx xxxxx 2 (XXX-1) ..........8 antigenních X xxxxxxxx*
Xxxxx poliomyelitis xxxxxxxxxxx xxxxx 3 (Xxxxxxx)........32 xxxxxxxxxxx X xxxxxxxx*
* xxxx množství xxxxxxxxxxxxxx antigenů stanovené xxxxxx vhodné xxxxxxxxxxxxx xxxxxx.
1xx) xxxxxxxx látky xxxxx xxxxxxxxxxxxx infekcím xxxxxxxxx v sekvenčním xxxxxxxx:
1xxx) xxxxxxxxxxx očkovací xxxxx xxxxxxxx:
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 11 2,2 µg
Streptococci xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 31 2,2 µx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 41 2,2 µx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 51 2,2 µx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 6X1 2,2 µx
Xxxxxxxxxxxx pneumoniae xxxxxxxxxxxxxxx xxxxxxxxx 6B1 4,4 µg
Streptococci pneumoniae xxxxxxxxxxxxxxx xxxxxxxxx 7F1 2,2 µx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 9X1 2,2 µx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 141 2,2 µx
Xxxxxxxxxxxx pneumoniae xxxxxxxxxxxxxxx xxxxxxxxx 18X1 2,2 µx
Xxxxxxxxxxxx pneumoniae xxxxxxxxxxxxxxx xxxxxxxxx 19X1 2,2 µg
Streptococci xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 19X1 2,2 µg
Streptococci xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 23X1 2,2 µg
1 Xxxxxxxxxx x xxxxxx xxxxxxxxx XXX197 x xxxxxxxxxx xx xxxxxxxxxxx xxxxxxx (0,125 xx hliníku).
1chb) xxxxxxxxxxxxxxx xxxxxxxx xxxxx xxxxxxxx:
xx 25 mikrogramech xxxxxxxxxxxxx 23 pneumokokových xxxxxxxxxxxxxxxxx sérotypů: 1, 2, 3, 4, 5, 6X, 7X, 8, 9X, 9X, 10X, 11X, 12F, 14, 15X, 17X, 18X, 19X, 19X, 20, 22X, 23F, 33X.
1x) očkovací látka xxxxx záškrtu, dávivému xxxxx (xxxxxxxxxx xxxxx), xxxxxx, xxxxxx xxxxxxxx xxxxx (xxxxxxxxxxxx xxxxx):
Xxxxx xxxxx (0,5 xx) xxxxxxxx:
Xxxxxxxxxxx xxxxxxxxxx1 - xx xxxx xxx 2 xxxxxxxxxxx xxxxxxxx (XX) (2,5 Xx)
Xxxxxx xxxxxxxxxx1 - xx xxxx než 20 xxxxxxxxxxxxx xxxxxxxx (XX) (5 Xx)
Xxxxxxxxxxx xxxxxxxxx xxxxxxxx:
Xxxxxxxxx anatoxinum1 - 8 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxxxxxxx xxxxxxxxxxxx1 - 8 xxxxxxxxxx
Xxxxxxxxx1 2,5 mikrogramů
Virus xxxxxxxxxxxxxxx inactivatum:
typus 1 (xxxx Xxxxxxx)2 - 40 D jednotek xxxxxxxx
xxxxx 2 (kmen XXX-1)2 - 8 X xxxxxxxx xxxxxxxx
xxxxx 3 (kmen Xxxxxxx)2 - 32 X xxxxxxxx antigenu
1 Xxxxxxxxxxx xx hydratovaný hydroxid xxxxxxx (Xx(XX)3) 0,3 xxxxxxxxx Al3+ x xxxxxxxxxxx xxxxxxx (XxXX4) 0,2 miligramu Xx3+
2 xxxxxxxxx xx XXXX xxxxxxx
XXXX
1xx) očkovací látka xxxxx xxxxxxx, dávivému xxxxx (xxxxxxxxxx forma), xxxxxx, dětské přenosné xxxxx (xxxxxxxxxxxx xxxxx):
Xxxxx xxxxx (0,5 ml) xxxxxxxx:
Xxxxxxxxxxx anatoxinum xxxxxxxxx 2 IU* (2,5 Xx)
Xxxxxx xxxxxxxxxx xxxxxxxxx 20 XX* (5 Xx)
Xxxxxxxxx xxxxxxxx:
Xxxxxxxxx xxxxxxxxxx 2,5 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxxxxxxxxx xxxxxxxxxxxx 5 xxxxxxxxxx
Xxxxxxxxxxx 3 xxxxxxxxxx
Xxxxxxxx, xxxx 2 et 3 5 mikrogramů
Virus poliomyelitidis (xxxxxxxxxxx)**
xxxxx 1 40 X xxxxxxxx xxxxxxxx
xxxxx 2 8 D xxxxxxxx xxxxxxxx
xxxxx 3 32 X xxxxxxxx xxxxxxxx
Xxxxxxxxxxx xx xxxxxxxxxxx xxxxxxx 1,5 xx (0,33 xx hliníku)
* Xxxx spodní xxxxxxx xxxxxxxxx xxxxxxxxxxxxx (x = 0,95) xxxxxxxx xxxxxx podle xxxxx xxxxxxxxx v Xxxxxxxxx xxxxxxxx.
** Kultivováno xx Xxxx buňkách.
1j) xxxxxxxx xxxxx xxxxx xxxxxxxxxxx (XXX xxxxxxx)
1x) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx X pro xxxxx zařazené xx xxxxxxxxxxxx xxxxxxxx:
Xxxxx dávka (0,5 xx) vakcíny xxxxxxxx:
Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X1,2,3 - 20 xxxxxxxxxx
1 xxxxxxxxxx xx XX04X xxxxxxxxxx: - 3-0-xxxxxx-4'-xxxxxxxxxxxx-xxxxx X (MPL)2 50 xxxxxxxxxx
2 xxxxxxxxxxx xx fosforečnan xxxxxxx (xxxxxx 0,5 xxxxxxxxx Xx3+)
3 xxxxxxxx na xxxxxxx kvasinkových xxxxx (Xxxxxxxxxxxxx cerevisiae) rekombinantní XXX technologií.
2. Antigenní xxxxxxx xxxxxxxxxx xxxxx xxx zvláštní xxxxxxxx
2x) xxxxxxxx xxxxx xxxxx xxxxxx hepatitidě B xx xxxxxxx xxx xxxxxxx:
Xxxxx xxxxx xxxxxxxx:
Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx B - 20 mikrogramů
2b) xxxxxxxx látka xxxxx xxxxxxxxx
2x) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx X ve formuli xxx xxxxxxx:
Xxxxx xxxxx xxxxxxxx:
Xxxxxxxxx X xxxxx xxxxxxxxxxx
2x) očkovací xxxxx xxxxx xxxxxxxxxx, xxxxxxxxxx x xxxxxxxxx:
Xxxxx xxxxx xxxxxxxx:
Xxxxxxxxxxx xxxxx xxxxxxxxxx1 (Xxxxxxx) xxx. 103,0 xxxxxxxx xxxxx xxx xxxxxxxx xxxxxxx503
Xxxxxxxxxxx virus xxxxxxxxxx1 (RIT 4385) xxx. 103,7 xxxxxxxx xxxxx xxx xxxxxxxx xxxxxxx503
Xxxxxxxx xxxxx xxxxxxxxxx2 (Xxxxxx XX 27/3) xxx. 103,0 xxxxxxxx xxxxx xxx xxxxxxxx xxxxxxx503
1 xxxxxxxxx xx xxxxxxx xxxxxxxx xxxxxx
2 xxxxxxxxx na xxxxxxxx xxxxxxxxxxx xxxxxxx (XXX-5)
3 50% infekční dávka xxxxxxx xxxxxxx
XXXX
2xx) xxxxxxxx xxxxx xxxxx spalničkám, xxxxxxxxxx x xxxxxxxxx
Xx xxxxxxxxxx xxxxxxxx xxxxx xxxxx (0,5 xx):
Xxxxx xxxxxxxxxxx1 xxxxx attenuatum (xxxx Enders’ Xxxxxxxxx) xx méně než 1x103 CCID50*
Virus xxxxxxxxxxx1 xxxxx xxxxxxxxxx (xxxx Xxxxx Xxxx™, hladina X) xx xxxx xxx 12,5x103 CCID50*
Virus xxxxxxxx2 vivum attenuatum (xxxx Xxxxxx XX 27/3) xx xxxx xxx 1x103 CCID50*
* 50 % infekční xxxxx xxxxxxx xxxxxxx
1 xxxxxxxx na xxxxxxx xxxxxxxx xxxxxx.
2 vyrobeno xx lidských xxxxxxxxxxx xxxxxxxx XX-38 xxxxxxxxxxxxx.
3. Xxxxxxxxx složení xxxxxxxxxx xxxxx pro mimořádná xxxxxxxx
3x) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx X xx formuli xxx xxxxxxx:
Xxxxx xxxxxxxxx X xxxxxxxxxxx
3x) xxxxxxxx xxxxx xxxxx virové xxxxxxxxxx A ve xxxxxxx pro děti:
Virus xxxxxxxxx A inactivatum
3c) xxxxxxxx xxxxx proti xxxxxxxxxx, xxxxxxxxxx a xxxxxxxxx:
Xxxxx xxxxx xxxxxxxx:
Xxxxxxxxxxx xxxxx attenuatum1 (Xxxxxxx) xxx. 103,0 xxxxxxxx xxxxx xxx xxxxxxxx xxxxxxx503
Xxxxxxxxxxx xxxxx xxxxxxxxxx1 (XXX 4385) xxx. 103,7 infekční xxxxx xxx xxxxxxxx xxxxxxx503
Xxxxxxxx xxxxx xxxxxxxxxx2 (Xxxxxx XX 27/3) min. 103,0 xxxxxxxx xxxxx xxx buněčnou kulturu503
1 xxxxxxxxx na xxxxxxx xxxxxxxx xxxxxx
2 xxxxxxxxx xx xxxxxxxx diploidních xxxxxxx (MRC-5)
3 50% xxxxxxxx xxxxx xxxxxxx xxxxxxx
XXXX
3xx) xxxxxxxx xxxxx xxxxx xxxxxxxxxx, xxxxxxxxxx x xxxxxxxxx
Xx rozpuštění xxxxxxxx xxxxx dávka (0,5 xx):
Xxxxx morbillorum1 xxxxx attenuatum (xxxx Xxxxxx’ Xxxxxxxxx) ne xxxx xxx 1x103 XXXX50*
Xxxxx xxxxxxxxxxx1 xxxxx xxxxxxxxxx (xxxx Jeryl Xxxx™, xxxxxxx B) xx xxxx xxx 12,5x103 XXXX503
Xxxxx xxxxxxxx2 xxxxx xxxxxxxxxx (xxxx Xxxxxx XX 27/3) xx méně xxx 1x1103 XXXX503
* 50% xxxxxxxx dávka xxxxxxx xxxxxxx
1 xxxxxxxx xx xxxxxxx kuřecích xxxxxx.
2 xxxxxxxx xx xxxxxxxx xxxxxxxxxxx plicních XX-38 xxxxxxxxxxxxx.
&xxxx;
Xxxxxxx:
xxxx. XXXx. Xxxxx, XXx., XXX, XXXX, x. x.
Informace
Právní xxxxxxx č. 41/2023 Xx. xxxxx xxxxxxxxx xxxx 22.2.2023.
Xx xxx xxxxxxxx xxxxxx xxxxxxx nebyl měněn xx xxxxxxxxx.
Xxxxx xxxxxxxxxxxx xxxxxxxx xxxxx xxxxxx xxxxxxxx xxxxxxxx x xxxxxxxx xxxx xxxxxxxxxxxxx, xxxxx xx xxxx xxxxxx derogační změna xxxxx xxxxxxxxx xxxxxxxx xxxxxxxx.